This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Philip Gotwals
Global Head, Business Development and Licensing at Novartis Institutes for BioMedical Research, Inc.

Profile

Philip Gotwals is Global Head, BD&L, at Novartis Institutes for BioMedical Research (NIBR) where he oversees business development efforts for all disease areas and technology platforms. Previously, Phil was Executive Director, Exploratory Immuno-Oncology, and instrumental in building NIBR’s immuno-oncology strategic research area including the CAR-T platform. He has more than 20 years of experience in the biotechnology and pharmaceutical industries, leading internal and collaborative R&D programs from drug discovery to new drug application filing, and leading the licensing of product candidates.  Phil holds a Ph.D. in genetics from the University of California at Berkeley, and completed postdoctoral research at the Massachusetts Institute of Technology.

Agenda Sessions

  • Featured Presentation - NIBR BD&L: Innovation Through Partnering

    15:45